Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
26 hedge funds and large institutions have $2.34M invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
74.94% more ownership
Funds ownership: 0% → 74.94% (+75%)
35% more capital invested
Capital invested by funds: $1.74M → $2.34M (+$601K)
18% more funds holding
Funds holding: 22 → 26 (+4)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Moore Capital Management
New York
|
+$81K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$77.2K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$51.1K |
| 4 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
+$46.3K |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$44.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$38.6K |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$12.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.3K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$3.07K |
OACCW Hedge Fund Activity: Q2 2025 in Review
26 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q2 2025, worth a combined $2.34M — up 35% from $1.74M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new OACCW positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Moore Capital Management, opening a new position worth an estimated $81K. The largest seller was Hudson Bay Capital Management, cutting an estimated $38.6K.
- 26 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q2 2025, up from 22 in Q1 2025.
- Funds reported $2.34M of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q2 2025, up 35% quarter-over-quarter.
- 5 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q2 2025 and 1 closed out, a net change of +4 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q2 2025 was Moore Capital Management, an estimated $81K added.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant seller in Q2 2025 was Hudson Bay Capital Management, an estimated $38.6K sold.
Based on aggregated 13F filings for Q2 2025.